We are live on ! Find out more
DARE icon

Dare Bioscience
DARE

37 hedge funds and large institutions have $8.07M invested in Dare Bioscience in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 12 increasing their positions, 4 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 4

43% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 7

26% more capital invested

Capital invested by funds: $6.4M → $8.07M (+$1.67M)

9% more funds holding

Funds holding: 34 → 37 (+3)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% less ownership

Funds ownership: 0.57% → 0.57% (-0%)

Holders
37
Holders Change
+3
Holders Change %
+8.82%
% of All Funds
0.65%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
10
Increased
12
Reduced
4
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$421K
2
Renaissance Technologies
Renaissance Technologies
New York
+$413K
3
Goldman Sachs
Goldman Sachs
New York
+$390K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$370K
5
Jane Street
Jane Street
New York
+$298K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$104K
2
TSS
Two Sigma Securities
New York
-$84K
3
Two Sigma Advisers
Two Sigma Advisers
New York
-$62K
4
BlackRock
BlackRock
New York
-$20K
5
UBS Group
UBS Group
Switzerland
-$17.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$3.62M +$370K +18,754 +12%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$946K +$421K +21,364 +83%
PVMCV
3
Polaris Venture Management Co V
Massachusetts
$545K – – –
Renaissance Technologies
4
Renaissance Technologies
New York
$541K +$413K +20,954 +346%
Goldman Sachs
5
Goldman Sachs
New York
$426K +$390K +19,807 +1,350%
Jane Street
6
Jane Street
New York
$303K +$298K +15,132 New
State Street
7
State Street
Massachusetts
$269K +$162K +8,225 +158%
BlackRock
8
BlackRock
New York
$205K -$20K -1,015 -9%
FFS
9
Founders Financial Securities
Maryland
$164K – – –
VF
10
Virtu Financial
New York
$156K +$154K +7,790 New
TRCT
11
Tower Research Capital (TRC)
New York
$124K +$120K +6,099 +6,931%
Northern Trust
12
Northern Trust
Illinois
$119K +$13.9K +706 +14%
Citadel Advisors
13
Citadel Advisors
Florida
$111K +$109K +5,551 New
IVM
14
InterWest Venture Management
California
$104K +$19.2K +975 +23%
XT
15
XTX Topco
Cayman Islands
$51K +$27.4K +1,391 +118%
Charles Schwab
16
Charles Schwab
California
$51K +$50.2K +2,544 New
Millennium Management
17
Millennium Management
New York
$45K +$44.5K +2,259 New
Commonwealth Equity Services
18
Commonwealth Equity Services
Massachusetts
$43K – – –
CIBC Private Wealth Group
19
CIBC Private Wealth Group
Georgia
$42K – – –
PSIWM
20
Paradigm Strategies in Wealth Management
Minnesota
$39K +$21.5K +1,092 +131%
HighTower Advisors
21
HighTower Advisors
Illinois
$36K -$13.1K -667 -27%
UCFA
22
United Capital Financial Advisors
Texas
$25K – – –
Two Sigma Investments
23
Two Sigma Investments
New York
$21K +$20.9K +1,062 New
GCP
24
GSA Capital Partners
United Kingdom
$20K +$19.8K +1,004 New
IA
25
IFS Advisors
Kansas
$19K – – –
1
2

DARE Hedge Fund Activity: Q3 2021 in Review

37 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q3 2021, worth a combined $8.07M — up 26% from $6.4M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new DARE positions and 7 closed out — a net gain of 3 holders — while 12 added to existing stakes and 4 trimmed.

The largest buyer was Geode Capital Management, adding an estimated $421K. The largest seller was Morgan Stanley, cutting an estimated $104K.

  • 37 institutional investors held Dare Bioscience (DARE) as of Q3 2021, up from 34 in Q2 2021.
  • Funds reported $8.07M of Dare Bioscience stock for Q3 2021, up 26% quarter-over-quarter.
  • 10 funds opened new Dare Bioscience positions in Q3 2021 and 7 closed out, a net change of +3 holders.
  • The largest Dare Bioscience buyer in Q3 2021 was Geode Capital Management, an estimated $421K added.
  • The largest Dare Bioscience seller in Q3 2021 was Morgan Stanley, an estimated $104K sold.

Based on aggregated 13F filings for Q3 2021.